• Study of orforglipron in people with high blood pressure who are overweight or have obesity

    Not recruiting

    3 1
    Czechia Germany Greece Poland Spain

  • Study of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Finland France Germany Greece Hungary +5

  • Study Comparing Selpercatinib, Cabozantinib, and Vandetanib for Patients with Advanced RET-Mutant Medullary Thyroid Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Greece Italy +3

  • Safety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study

    Not recruiting

    2 1
    Denmark France Portugal Spain

  • Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of varegacestat (AL102) in patients with progressing desmoid tumors

    Not recruiting

    4 1
    Investigated Drugs:
    Belgium Germany Italy The Netherlands Poland Spain

  • Study on BI 3032950 for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Poland Slovakia

  • Study on Ulcerative Colitis: Effects of Filgotinib and Gallium (68Ga) Chloride in Patients with Intestinal Fibrosis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands

  • Efficacy and Safety of E2086 in Adults with Narcolepsy: A Randomized, Double‑Blind, Placebo‑Controlled Trial

    Not recruiting

    2 1
    Investigated Diseases:
    Belgium Germany Italy Spain

  • Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Estonia Finland +6

powered by